Zyrtec-D Paragraph IV Application Submitted To FDA
This article was originally published in The Tan Sheet
Executive Summary
A generic version of Pfizer's Zyrtec-D 12 Hour is among the Paragraph IV abbreviated new drug applications submitted to FDA early this summer